USANA Health Sciences, Inc.

NYSE:USNA

38.42 (USD) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994
Revenue 921.01998.6011,186.4641,134.6441,060.9021,189.2481,047.2651,006.083918.499790.471718.175648.726581.939517.644436.94429.012423.149374.19327.742272.824200.013133.776114.28123.18129.4121.685.256.724.57.3
Cost of Revenue 189.395193.89217.898209.111187.503200.71179.404180.19159.682140.794127.435115.804101.69295.48289.80388.87887.89189.54578.01666.82244.42233.39232.80232.1582121.915.610.85.40
Gross Profit 731.615804.711968.566925.533873.399988.538867.861825.893758.817649.677590.74532.922480.247422.162347.137340.134335.258284.645249.726206.002155.591100.38481.47891.022108.499.769.645.919.17.3
Gross Profit Ratio 0.7940.8060.8160.8160.8230.8310.8290.8210.8260.8220.8230.8210.8250.8160.7940.7930.7920.7610.7620.7550.7780.750.7130.7390.8380.820.8170.810.781
Reseach & Development Expenses 11.44611.56311.11210.63310.25910.2428.9528.8426.425.1285.0834.66400003.3633.1972.3392.0311.3841.0351.081.411.41.41.20.80.30
General & Administrative Expenses 256.989262.304279.107261.186267.731275.059265.094234.194208.995184.531166.208154.237402.991353.946296.346000000000000000
Selling & Marketing Expenses 394.257434.793519.267487.856459.478525.126470.263453.077408.16349.044307.82280.506000000000000000000
SG&A 627.098697.097798.374749.042727.209800.185735.357687.271617.155533.575474.028434.743402.991353.946296.346292.137261.194219.105189.024159.125123.08886.55676.19879.97188.579.755.636.4150
Other Expenses 0.0071.0070.451.4574.3063.1572.136-0.070.927-0.449-0.1310.247164.236137.705106.5689.43182.49256.70650.68237.61134.25317.78211.114.1864.53.42.20.80.30
Operating Expenses 638.544697.097798.374749.042727.209800.185735.357687.271617.155533.575474.028434.743402.991353.946296.346292.137264.557222.302191.363161.156124.47287.59177.27885.56794.484.5593815.60
Operating Income 93.071107.614170.192176.491146.19188.353132.504138.622141.662116.102116.71298.17977.25668.21650.79147.99770.70162.34358.36344.84631.11912.7934.25.4551415.210.67.93.57.3
Operating Income Ratio 0.1010.1080.1430.1560.1380.1580.1270.1380.1540.1470.1630.1510.1330.1320.1160.1120.1670.1670.1780.1640.1560.0960.0370.0440.1080.1250.1240.1390.1431
Total Other Income Expenses Net 9.3821.0070.451.4574.3063.1572.136-0.070.927-0.449-0.1310.2470.2220.6480.187-1.1330.7220.867-0.062-0.3390.1170.011-0.0270.381-4.40.20.20.30.20
Income Before Tax 102.453108.621170.642177.948150.496191.51134.64138.552142.589115.653116.58198.42677.47868.86450.97846.32171.17263.75458.8545.07931.31112.5723.5084.7789.615.410.78.13.70
Income Before Tax Ratio 0.1110.1090.1440.1570.1420.1610.1290.1380.1550.1460.1620.1520.1330.1330.1170.1080.1680.170.180.1650.1570.0940.0310.0390.0740.1270.1260.1430.1510
Income Tax Expense 38.66539.27154.13753.28449.9765.28672.10538.51147.91739.01737.55731.99326.72623.21317.42216.37625.24322.48819.85614.30210.4944.0691.3091.9113.75.94.13.11.4-0.3
Net Income 63.78869.35116.505124.664100.526126.22462.535100.04194.67276.63679.02466.43350.75245.65133.55629.94545.31741.26638.99430.77720.8178.5032.1992.8675.99.56.652.30.3
Net Income Ratio 0.0690.0690.0980.110.0950.1060.060.0990.1030.0970.110.1020.0870.0880.0770.070.1070.110.1190.1130.1040.0640.0190.0230.0460.0780.0770.0880.0940.041
EPS 3.313.65.785.894.445.362.64.093.713.112.852.41.71.431.10.941.361.151.030.810.550.230.0580.0730.120.180.130.10.0530.008
EPS Diluted 3.33.595.735.864.415.122.533.993.592.82.782.231.631.431.090.931.321.10.990.760.490.210.0580.0730.120.170.120.0950.050.008
EBITDA 113.466107.614170.192176.491146.19188.353132.504138.622141.662116.102116.71298.17977.03467.56850.60455.82775.31267.03864.32950.02534.87916.9198.3439.2622.918.412.68.43.67.3
EBITDA Ratio 0.1230.1080.1430.1560.1380.1580.1270.1380.1540.1470.1630.1510.1320.1310.1160.130.1780.1790.1960.1830.1740.1260.0730.0750.1770.1510.1480.1480.1471